• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定肝硬化合并静脉曲张出血患者经颈静脉肝内门体分流术后门静脉压力梯度的最佳测量时机和血流动力学目标。

Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.

作者信息

Lv Yong, Wang Qiuhe, Luo Bohan, Bai Wei, Li Menghao, Li Kai, Wang Zhengyu, Xia Dongdong, Guo Wengang, Li Xiaomei, Yuan Jie, Zhang Na, Wang Xing, Xie Huahong, Pan Yanglin, Nie Yongzhan, Yin Zhanxin, Fan Daiming, Han Guohong

机构信息

National Clinical Research Center for Digestive Diseases and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China; Department of Liver Diseases and Digestive Interventional Radiology, National Clinical Research Centre for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.

Department of Liver Diseases and Digestive Interventional Radiology, National Clinical Research Centre for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.

出版信息

J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22.

DOI:10.1016/j.jhep.2024.08.007
PMID:39181214
Abstract

BACKGROUND & AIMS: The optimal timing of measurement and hemodynamic targets of portacaval pressure gradient (PPG) after transjugular intrahepatic portosystemic shunt (TIPS) placement remain unclear. This study aimed to identify the ideal moment for hemodynamic measurements and the optimal target of PPG in patients undergoing covered TIPS for variceal bleeding.

METHODS

Between May 2018 and December 2021, 466 consecutive patients with recurrent variceal bleeding treated with covered TIPS were prospectively included. Post-TIPS PPG was measured immediately (immediate PPG), 24-72 hours (early PPG), and again 1 month (late PPG) after TIPS placement. The agreement among PPGs measured at different time points was assessed by intra-class correlation coefficient (ICC) and Bland-Altman method. The unadjusted and confounder-adjusted effects of PPGs on clinical outcomes (portal hypertensive complications [PHCs], overt hepatic encephalopathy [OHE], further decompensation, and death) were assessed using Fine and Gray competing risk regression models.

RESULTS

The agreement between early PPG and late PPG (ICC: 0.34) was better than that between immediate PPG and late PPG (ICC: 0.23, p <0.001). Early PPG revealed an excellent predictive value for PHCs (early PPG≥ vs. <12 mmHg: adjusted hazard ratio 2.17, 95% CI 1.33-3.55, p = 0.002) and OHE (0.40, 95% CI 0.17-0.91, p = 0.030), while immediate PPG did not. Late PPG showed a predictive value for PHC risk but not OHE. By targeting the lowest risk of further decompensation, we identified an optimal hemodynamic target with early PPG ranging from 11 to 14 mmHg that was associated with a decreased risk of OHE and effective prevention of PHCs.

CONCLUSIONS

PPG measured 24 to 72 hours after TIPS correlates with long-term PPG and clinical outcomes, and a hemodynamic target PPG of 11-14 mmHg is associated with reduced encephalopathy but not compromised clinical efficacy.

IMPACT AND IMPLICATIONS

The optimal timing of measurement and hemodynamic targets of portacaval pressure gradient (PPG) after transjugular intrahepatic portosystemic shunt (TIPS) remain unclear. Here we show that post-TIPS PPG measured at least 24 hours but not immediately after the procedure correlated with long-term PPG and clinical events. Thus, PPG measurements taken at least 24 hours after TIPS should be used to guide decision making in order to improve clinical outcomes. Targeting a post-TIPS PPG of 11-14 mmHg or a 20%-50% relative reduction from pre-TIPS baseline measured 24-72 hours after the procedure was associated with reduced encephalopathy but not compromised clinical efficacy. Thus, these criteria could be used to guide TIPS creation and revision in patients with cirrhosis and variceal bleeding undergoing covered TIPS.

CLINICAL TRIAL REGISTRATION NUMBER

ClinicalTrials.gov, ID: NCT03590288.

摘要

背景与目的

经颈静脉肝内门体分流术(TIPS)置入术后门腔静脉压力梯度(PPG)的最佳测量时机及血流动力学目标仍不明确。本研究旨在确定接受覆膜TIPS治疗静脉曲张出血患者进行血流动力学测量的理想时机以及PPG的最佳目标值。

方法

2018年5月至2021年12月,前瞻性纳入466例连续接受覆膜TIPS治疗复发性静脉曲张出血的患者。TIPS术后立即测量(即时PPG)、术后24 - 72小时(早期PPG)以及术后1个月再次测量(晚期PPG)PPG。采用组内相关系数(ICC)和Bland - Altman方法评估不同时间点测量的PPG之间的一致性。使用Fine和Gray竞争风险回归模型评估PPG对临床结局(门静脉高压并发症[PHC]、显性肝性脑病[OHE]、进一步失代偿和死亡)的未调整和混杂因素调整后的影响。

结果

早期PPG与晚期PPG之间的一致性(ICC:0.34)优于即时PPG与晚期PPG之间的一致性(ICC:0.23,p <0.001)。早期PPG对PHC(早期PPG≥ vs. <12 mmHg:调整后风险比2.17,95% CI 1.33 - 3.55,p = 0.002)和OHE(0.40,95% CI 0.17 - 0.91, p = 0.030)具有良好的预测价值,而即时PPG则无。晚期PPG对PHC风险有预测价值,但对OHE无预测价值。通过针对进一步失代偿的最低风险,我们确定了早期PPG在11至14 mmHg范围内的最佳血流动力学目标,该目标与OHE风险降低以及有效预防PHC相关。

结论

TIPS术后24至72小时测量的PPG与长期PPG及临床结局相关,血流动力学目标PPG为11 - 14 mmHg与脑病减少相关,但不影响临床疗效。

影响与意义

经颈静脉肝内门体分流术(TIPS)后门腔静脉压力梯度(PPG)的最佳测量时机及血流动力学目标仍不明确。在此我们表明,TIPS术后至少24小时而非术后立即测量的PPG与长期PPG及临床事件相关。因此,TIPS术后至少24小时进行的PPG测量应用于指导决策以改善临床结局。将TIPS术后PPG目标设定为11 - 14 mmHg或术后24 - 72小时相对于TIPS术前基线降低20% - 50%与脑病减少相关,但不影响临床疗效。因此,这些标准可用于指导接受覆膜TIPS治疗的肝硬化和静脉曲张出血患者的TIPS创建和修订。

临床试验注册号

ClinicalTrials.gov,ID:NCT03590288

相似文献

1
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.确定肝硬化合并静脉曲张出血患者经颈静脉肝内门体分流术后门静脉压力梯度的最佳测量时机和血流动力学目标。
J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22.
2
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
3
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.肝硬化失代偿期食管静脉曲张出血患者的二级预防:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013122. doi: 10.1002/14651858.CD013122.pub2.
4
Early Dynamics of Portal Pressure Gradient After TIPS Insertion Predict Mortality.经颈静脉肝内门体分流术(TIPS)置入后门静脉压力梯度的早期动态变化可预测死亡率。
Aliment Pharmacol Ther. 2025 Apr;61(7):1175-1182. doi: 10.1111/apt.18503. Epub 2025 Jan 16.
5
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.肝硬化患者胃静脉曲张出血的预先性经颈静脉肝内门体分流术(GAVAPROSEC):一项开放标签随机临床试验
Lancet Gastroenterol Hepatol. 2025 Aug;10(8):726-733. doi: 10.1016/S2468-1253(25)00156-6. Epub 2025 Jun 12.
6
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.肌肉减少症是经颈静脉肝内门体分流术肝性脑病和死亡率的一个风险因素:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12.
7
Freiburg index of post-TIPS survival (FIPS) identifies patients at risk of further decompensation and ACLF after TIPS.经颈静脉肝内门体分流术后生存的弗莱堡指数(FIPS)可识别经颈静脉肝内门体分流术后有进一步失代偿和急性肝衰竭风险的患者。
J Hepatol. 2025 Feb 4. doi: 10.1016/j.jhep.2025.01.030.
8
Optimal timing for TIPS and PSE combination treatment in patients with cirrhosis-related variceal bleeding and hypersplenism.肝硬化相关性静脉曲张出血合并脾功能亢进患者经颈静脉肝内门体分流术(TIPS)与脾动脉栓塞术(PSE)联合治疗的最佳时机
Acad Radiol. 2025 Mar;32(3):1534-1546. doi: 10.1016/j.acra.2024.09.003. Epub 2024 Oct 9.
9
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化患者食管静脉曲张出血的治疗:网状荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 10;4(4):CD013155. doi: 10.1002/14651858.CD013155.pub2.
10
Fine-Needle Portosystemic Pressure Gradient as a Reference for Portal Hypertension in Patients with Intrahepatic Venovenous Shunt: A Prospective Study.细针门静脉系统压力梯度作为肝内静脉分流患者门静脉高压的参考指标:一项前瞻性研究
J Vasc Interv Radiol. 2025 Apr;36(4):625-634.e2. doi: 10.1016/j.jvir.2024.12.020. Epub 2024 Dec 20.

引用本文的文献

1
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats.维格列汀与沙库巴曲缬沙坦联合治疗可减轻肝硬化大鼠的门静脉高压并抑制可溶性环氧化物水解酶。
World J Gastroenterol. 2025 Sep 7;31(33):109562. doi: 10.3748/wjg.v31.i33.109562.
2
Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation.肝病学中的经颈静脉诊断程序:适应证、技术与解读
JHEP Rep. 2025 Apr 29;7(8):101437. doi: 10.1016/j.jhepr.2025.101437. eCollection 2025 Aug.
3
Feasibility, Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis.
经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成的可行性、安全性及疗效
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102580. doi: 10.1016/j.jceh.2025.102580. Epub 2025 Apr 12.
4
Controlled expansion stent grafts versus legacy stent grafts for transjugular intrahepatic portosystemic shunt: a single-centre retrospective study on the incidence of hepatic encephalopathy.经颈静脉肝内门体分流术使用可控扩张式支架移植物与传统支架移植物的比较:关于肝性脑病发生率的单中心回顾性研究
CVIR Endovasc. 2025 May 24;8(1):48. doi: 10.1186/s42155-025-00557-8.
5
Correlation and consistency analysis between various indirect portal pressure gradients and actual portal pressure gradient.各种间接门静脉压力梯度与实际门静脉压力梯度之间的相关性及一致性分析
BMC Gastroenterol. 2025 Apr 10;25(1):241. doi: 10.1186/s12876-025-03816-z.
6
Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on "Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis".经颈静脉肝内门体分流术治疗全身炎症:关于“经颈静脉肝内门体分流术置入可导致失代偿期肝硬化患者全身炎症持续逆转”的社论
Clin Mol Hepatol. 2025 Apr;31(2):615-619. doi: 10.3350/cmh.2024.1180. Epub 2025 Jan 6.